Synapse - Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay

Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay Meeting Abstract

Authors:	Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; Sabbatini, P.; Deangelis, L. M.; Gutin, P. H.; Rosenblum, M.; Mellinghoff, I. K.; Tabar, V.; Chan, T. A.; Briggs, S.; Huse, J. T.; Brennan, C. W.
Abstract Title:	Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
Meeting Title:	51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	15 Suppl.
Meeting Dates:	2015 May 29-Jun 2
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-05-20
Language:	English
ACCESSION:	WOS:000358036900515
PROVIDER:	wos
DOI:	10.1200/JCO.2015.33.15_suppl.2057
Notes:	Meeting Abstract: 2057 -- Source: Wos